Rocket Pharmaceuticals Inc (RCKT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2026 | 03-2026 | 12-2025 | 09-2025 | 06-2025 | |
| Operating Expenses | 46,922 | 48,511 | 43,963 | 52,247 | 71,149 |
| Operating Income | -46,922 | -48,511 | -43,963 | -52,247 | -71,149 |
| Interest Expense | 473 | 473 | 473 | 473 | 473 |
| Other Income | 179,230 | 1,390 | 1,898 | 2,388 | 2,703 |
| Pre-tax Income | 131,835 | -47,594 | -42,538 | -50,332 | -68,919 |
| Income Tax | 8,621 | N/A | N/A | N/A | N/A |
| Net Income Continuous | 123,214 | -47,594 | -42,538 | -50,332 | -68,919 |
| Net Income | $123,214 | $-47,594 | $-42,538 | $-50,332 | $-68,919 |
| EPS Basic Total Ops | 1.09 | -0.42 | -0.38 | -0.45 | -0.62 |
| EPS Basic Continuous Ops | 1.09 | -0.42 | -0.38 | -0.45 | -0.62 |
| EPS Diluted Total Ops | 1.08 | -0.42 | -0.38 | -0.45 | -0.62 |
| EPS Diluted Continuous Ops | 1.08 | -0.42 | -0.38 | -0.45 | -0.62 |
| EPS Diluted Before Non-Recurring Items | -0.15 | -0.42 | -0.38 | -0.45 | -0.59 |
| EBITDA(a) | $-44,819 | $-46,365 | $-41,484 | $-49,007 | $-68,570 |